Healthcare Distribution Market to Rise at Moderate CAGR of 7.7% CAGR Through 2026
According to Acumen Research Healthcare Distribution Market is projected to reach USD 1,275 Billion by 2026, growing at a CAGR of 7.7% from 2019 to 2026.
Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1623
In 2018, North America dominated the regional market of healthcare distribution and the region is also expected to maintain its dominance over the forecast period. The US and other developed countries of the region have boosted the number of prescriptions in retail pharmacies with the implementation of programs to guarantee accessible healthcare for people. For instance, ADMA Biologics, Inc. announced the first commercial sales of ASCENIV with the approval from the U.S. Food and Drug Administration (FDA) in 2019. The biologic product is now commercially available for ordering in the U.S. through BioCare SD, ADMA's authorized distributor. ADMA is a commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics particularly for the treatment of immunodeficient patients.
By Type, pharmaceutical product distribution services of the healthcare distribution market have dominated the segment in the year 2018. The segment accounted for the largest market share owing to the increasing production of pharmaceutical formulations, ongoing R&D activities and increasing demand for pharmaceutical products in Asian countries. For instance, the regulation in the U.S. associated with the track and trace of drugs, manufactured by the pharmaceutical industry is enabling a large number of pharmaceutical manufacturers, shippers and wholesalers to adopt the blockchain-based network. Blockchain helps individual wholesalers by eliminating the need for managing large volumes of product lists and manufacturer addresses. Additionally, it complies with DQSA regulations with a reduction in errors and savings to the entire supply chain.
View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/healthcare-distribution-market
By end-user, retail pharmacies accounted for the largest share in the year 2018 owing to its dealing in large volumes for the pharmaceuticals on a daily basis. The rising implementation of programs by the US and various developed economies which ensures affordable healthcare for citizens results in increasing volume of prescriptions another factor accelerating the market value.
Some of the leading competitors are McKesson Corporation, Cardinal Health, Inc., AmerisourceBergen Corporation, Owens & Minor, Inc., Morris and Dickson Co., LLC, Curascript Specialty Distribution, FFF Enterprises, Inc., Medline Industries, Attain Med, Inc., and Dakota Drug among others. The major players involve in strategic partnerships for managing inventory, acquiring supplies, reducing costs and saving time for the expansion of the market share over the forecast period.
Some of the key observations regarding healthcare distribution industry include:
- United Parcel Service (UPS) of America, has unveiled service enhancements for existing and new healthcare and life sciences customers which include Re-Designed Quality Management System (QMS) for storage, inventory management and distribution of healthcare products, and Digitally Enabled Healthcare Network. UPS healthcare and life sciences provide global supply chain solutions and expertise to biopharma, pharmaceutical, and medical device companies.
- Thuocsi.vn, a Vietnamese online pharma marketplace gets US$500K seed financing by Singapore's Cocoon Capital and VietCapital Ventures. Thuocsi.vn is a startup operating under BuyMed, seeking to simplify the country's healthcare distribution.
- HiveIO, Inc. has announced the expansion of distribution agreement with Arrow Electronics, Inc. to North America. The announced agreement is likely to bring HiveIO's intelligent virtualization solution into Arrow's North American portfolio.
- In 2019, UPS Healthcare and Life Sciences have announced a new drone logistics project with a United States's leading healthcare provider, Kaiser Permanente. The new drone logistics service is named as UPS Flight Forward, and designed to support a 39-hospital network of Kaiser Permanente hospital campus.
- In 2019, a San Francisco based private equity firm, SkyKnight Capital has announced a successfully done investment into a nation's leading provider of home healthcare solutions, AeroCare Holdings, Inc.
- In Oct 2019, InComm, a payment technology company has announced a new partnership with a company listed under the top 40 largest private corporations in Forbes magazine named Giant Eagle, Inc. The new partnership aims to provide extra benefits to the five million InComm Healthcare's OTC Network cardholders, which can be drone from 200-plus locations of Giant Eagle's including Maryland, West Virginia, Pennsylvania, Ohio, and Indiana.
Market Segmentation
Market By Type
- Pharmaceutical Product Distribution Services
- OTC Drugs
- Generic Drugs
- Brand-name
- Biopharmaceutical Product Distribution Services
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Blood and Blood Products
- Other Products
- Medical Device Distribution Services
Market By End-User
- Retail Pharmacies
- Hospital Pharmacies
- Other
Market By Geography
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Key Questions Answered in the Report
The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-
- What is the overall structure of the market?
- What was the historical value and what is the forecasted value of the market?
- What are the key product level trends in the market?
- What are the market level trends in the market?
- Which of the market players are leading and what are their key differential strategies to retain their stronghold?
- Which are the most lucrative regions in the market space?
Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1623
TABLE OF CONTENT
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Pure Cashmere
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Healthcare Distribution Market By Type
1.2.2.1. Global Healthcare Distribution Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Healthcare Distribution Market Revenue Share By Type in 2018
1.2.2.3. Pharmaceutical Product Distribution Services
1.2.2.3.1. OTC Drugs
1.2.2.3.2. Generic Drugs
1.2.2.3.3. Brand-name
1.2.2.4. Biopharmaceutical Product Distribution Services
1.2.2.4.1. Monoclonal Antibodies
1.2.2.4.2. Vaccines
1.2.2.4.3. Recombinant Proteins
1.2.2.4.4. Blood and Blood Products
1.2.2.4.5. Other Products
1.2.2.5. Medical Device Distribution Services
1.2.3. Healthcare Distribution Market By End-User
1.2.3.1. Global Healthcare Distribution Market Revenue and Growth Rate Comparison By End-User (2015-2026)
1.2.3.2. Global Healthcare Distribution Market Revenue Share By End-User in 2018
1.2.3.3. Retail Pharmacies
1.2.3.4. Hospital Pharmacies
1.2.3.5. Other
1.2.4. Healthcare Distribution Market By Geography
1.2.4.1. Global Healthcare Distribution Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Healthcare Distribution Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Healthcare Distribution Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Healthcare Distribution Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Healthcare Distribution Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Healthcare Distribution Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Pure Cashmere Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Pure Cashmere Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Pure Cashmere Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Pure Cashmere Major Manufacturers in 2018
CHAPTER 4. HEALTHCARE DISTRIBUTION MARKET BY TYPE
4.1. Global Pure Cashmere Revenue By Type
4.2. Pharmaceutical Product Distribution Services
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. OTC Drugs
4.2.4. Generic Drugs
4.2.5. Brand-name
4.3. Biopharmaceutical Product Distribution Services
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.3. Monoclonal Antibodies
4.3.4. Vaccines
4.3.5. Recombinant Proteins
4.3.6. Blood and Blood Products
4.3.7. Other Products
4.4. Medical Device Distribution Services
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 5. HEALTHCARE DISTRIBUTION MARKET BY END-USER
5.1. Global Pure Cashmere Revenue By End-User
5.2. Retail Pharmacies
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Hospital Pharmacies
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Other
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
CHAPTER 6. NORTH AMERICA HEALTHCARE DISTRIBUTION MARKET BY COUNTRY
6.1. North America Healthcare Distribution Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Healthcare Distribution Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Healthcare Distribution Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
CHAPTER 7. EUROPE HEALTHCARE DISTRIBUTION MARKET BY COUNTRY
7.1. Europe Healthcare Distribution Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Healthcare Distribution Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
CHAPTER 8. ASIA-PACIFIC HEALTHCARE DISTRIBUTION MARKET BY COUNTRY
8.1. Asia-Pacific Healthcare Distribution Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Healthcare Distribution Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
CHAPTER 9. LATIN AMERICA HEALTHCARE DISTRIBUTION MARKET BY COUNTRY
9.1. Latin America Healthcare Distribution Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Healthcare Distribution Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
9.4. Mexico
9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
CHAPTER 10. MIDDLE EAST & AFRICA HEALTHCARE DISTRIBUTION MARKET BY COUNTRY
10.1. Middle East & Africa Healthcare Distribution Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East & Africa Healthcare Distribution Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. GCC
10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
10.4. South Africa
10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
10.5. Rest of Middle East & Africa
10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By End-User, 2015 - 2026 ($Million)
CHAPTER 11. COMPANY PROFILE
11.1. McKesson Corporation
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Cardinal Health, Inc.
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. AmerisourceBergen Corporation
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Owens & Minor, Inc.
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Morris and Dickson Co., LLC
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Curascript Specialty Distribution
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. FFF Enterprises, Inc.
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. FFF Enterprises, Inc.
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Medline Industries
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. Attain Med, Inc.
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Dakota Drug
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies
11.12. Others
11.12.1. Company Snapshot
11.12.2. Overview
11.12.3. Financial Overview
11.12.4. Product Portfolio
11.12.5. Key Developments
11.12.6. Strategies
CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope
The report is readily available and can be dispatched immediately after payment confirmation.
Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1623
If you would like to place an order or have any questions, please feel free to contact at sales@acumenresearchandconsulting.com | +1-407-915-4157 OR +1-408-900-9135
About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
Contact Us:
Phone: +14079154157 | +14089009135